UK markets close in 1 hour 46 minutes

BNTX Jan 2026 160.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
3.50000.0000 (0.00%)
As of 11:05AM EDT. Market open.
Full screen
Previous close3.5000
Open3.7000
Bid0.0000
Ask0.0000
Strike160.00
Expiry date2026-01-16
Day's range3.5000 - 3.7000
Contract rangeN/A
Volume2
Open interest143
  • Thomson Reuters StreetEvents

    Q1 2024 Autolus Therapeutics PLC Earnings Call

    Q1 2024 Autolus Therapeutics PLC Earnings Call

  • Benzinga

    European Patent Office Sides with Moderna In COVID-19 Vaccine Patent Dispute With Pfizer/BioNTech

    Moderna Inc (NASDAQ:MRNA) has reportedly achieved a significant victory at the European Patent Office (EPO) in its ongoing legal battle with Pfizer Inc (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) over the Covid-19 vaccine. The EPO’s Opposition Division upheld the validity of one of Moderna’s crucial patents, boosting the mRNA vaccine maker’s efforts to reclaim pandemic profits from its competitors, the Financial Times reports. Although Pfizer has nine months to appeal the decision, the EPO’s writte

  • GlobeNewswire

    BioNTech SE Shareholders Approve All Agenda Items at the Annual General Meeting 2024

    MAINZ, Germany, May 17, 2024 (GLOBE NEWSWIRE) — BioNTech SE (Nasdaq: BNTX, “BioNTech” or the “Company”) held its Annual General Meeting (“AGM”) today, May 17, 2024. A total of 87.51 per cent of the share capital was represented at the virtual assembly. There were 14 items on the agenda of the AGM. All resolutions proposed on the agenda items put to the vote at today’s AGM were approved by a large majority of the shareholders. “The past few years marked a leap in competence for BioNTech,” said He